Intervention
protein expression analysis
ClinicalTrials.gov intervention label
Explore related research
Search across original and mapped recordsSearch results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 38 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
38 shownCollecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung CancerNCT00897117 · 2001-05-01
RECRUITINGBiomarkers in Tissue Samples From Patients With Breast Cancer Treated With BevacizumabNCT01156168 · 2011-04-05
COMPLETEDLow-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer SurvivorsNCT01196936 · 2010-09-01
ACTIVE_NOT_RECRUITINGVorinostat in Treating Women With Ductal Carcinoma in Situ of the BreastNCT00788112 · 2009-07-01
COMPLETEDPTC299 in Treating Patients With HIV-Related Kaposi SarcomaNCT00686842 · 2008-09-01
TERMINATEDSorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to ChemotherapyNCT00801385 · 2008-09-01
UNKNOWNPaclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerNCT00729612 · 2008-08-14
COMPLETEDStudy of Tissue and Blood Samples From Patients With Recurrent Prostate Cancer Who Received Lapatinib on Clinical Trial ECOG-E5803NCT00897351 · 2008-07-10
COMPLETEDExemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast CancerNCT00674557 · 2008-06-01
TERMINATEDRucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian CancerNCT00664781 · 2007-12-01
COMPLETEDErlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung CancerNCT00499655 · 2007-11-01
COMPLETEDProteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerNCT00550537 · 2007-10-01
COMPLETEDNelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By SurgeryNCT00589056 · 2007-06-01
COMPLETEDGenetics of Women With Lobular Carcinoma in Situ of the BreastNCT00536718 · 2007-06-01
UNKNOWNTamoxifen Resistance in Women With Stage I, Stage II, Stage IIIA, or Stage IIIB Breast CancerNCT00899197 · 2007-05-01
TERMINATEDBiomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or VermiculiteNCT00897247 · 2007-01-01
COMPLETEDTumor Response to Pemetrexed Disodium in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Enrolled in Clinical Trial MCCRC-RC0524NCT00898820 · 2006-11-01
COMPLETEDLaboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous TreatmentNCT00673569 · 2006-09-01
COMPLETEDS9313A Protein Expression Analysis of Breast Cancer Tissue Microarrays From Clinical Trial SWOG-9313NCT00896727 · 2006-07-17
COMPLETEDBiomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17NCT00897065 · 2006-06-01
UNKNOWNPaclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)NCT00499083 · 2006-05-01
COMPLETEDCalcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone TherapyNCT00524589 · 2006-04-01
TERMINATEDIdentifying Genes That Predict Recurrence in Women With Breast Cancer Treated With ChemotherapyNCT00897299 · 2005-10-07
COMPLETEDONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous TreatmentNCT00425672 · 2005-09-01
COMPLETEDOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerNCT00900302 · 2005-04-01
COMPLETEDBortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid TumorsNCT00389805 · 2005-03-01
COMPLETEDBiomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by SurgeryNCT00665457 · 2004-04-15
TERMINATEDStudying Cells Collected Through Ductal Lavage in Women Undergoing Surgery for Ductal Carcinoma In Situ or Other Breast CancerNCT00896857 · 2004-04-01
COMPLETEDDocetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast CancerNCT00343512 · 2004-02-01
TERMINATEDNipple Aspiration, Ductal Lavage, and Duct Endoscopy in Screening Women at Moderate-to-High Risk of Developing Breast CancerNCT00081003 · 2003-11-01
COMPLETEDSerum and Exhaled Breath Condensate MALDI-MS of Lung Cancer. (SPORE)NCT00898209 · 2003-04-01
TERMINATEDIsotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone TherapyNCT00176527 · 2002-11-01
TERMINATEDErlotinib in Treating Patients With Breast Cancer That Can Be Removed by SurgeryNCT00633750 · 2002-08-01
COMPLETEDVaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian CancerNCT00436254 · 2001-10-01
COMPLETEDNipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast DiseaseNCT00813878 · 2001-07-01
TERMINATEDIdentifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy ParticipantsNCT00899028 · 2001-05-01
COMPLETEDUMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With CancerNCT00900094 · 2000-06-01
COMPLETEDStudying Stored Samples From Patients With Localized Prostate Cancer Treated on Clinical Trial NCI-00-C-0154NCT00535834
COMPLETEDCommon conditions
Breast Cancer18Lung Cancer11Prostate Cancer4Ovarian Cancer2Stage IIIA Breast Cancer2Stage IIIB Breast Cancer2Stage IIIC Breast Cancer2Stage IV Breast Cancer2brca1 Mutation Carrier1brca2 Mutation Carrier1Cancer1Colorectal Cancer1Esophageal Cancer1Estrogen Receptor1Her-21HER2-positive Breast Cancer1Kaposi's Sarcoma1Liver Cancer1Male Breast Cancer1Malignant Mesothelioma1Pancreatic Cancer1Pgr1Pulmonary Complications1Recurrent Breast Cancer1Recurrent Non-small Cell Lung Cancer1
Mapped diseases appearing in these trials
Shared study participation does not establish that this intervention treats a disease.
Leading sponsors
Vanderbilt-Ingram Cancer Center
5
Cancer Research UK
2
City of Hope Medical Center
2
ECOG-ACRIN Cancer Research Group
2
University of Nebraska
2
University of Washington
2
Wake Forest University Health Sciences
2
Abramson Cancer Center at Penn Medicine
1
AIDS Malignancy Consortium
1
Barbara Ann Karmanos Cancer Institute
1
Eastern Cooperative Oncology Group
1
Greg Otterson
1
Massachusetts General Hospital
1
Mayo Clinic
1
National Cancer Research Network
1
Trial status mix
COMPLETED24
TERMINATED9
UNKNOWN3
ACTIVE_NOT_RECRUITING1
RECRUITING1
Phase mix
PHASE218
PHASE16
NA1
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.